Cargando…

Pregnancy outcomes after administration of monoclonal antibody therapy for COVID-19

Detalles Bibliográficos
Autores principales: Martinez-Baladejo, Maria T., Graul, Ashley, Gifford, Tyler, McGorry, Dennis, Bell, Joseph, Anastasio, Hannah, Zighelboim, Israel, Tolosa, Jorge E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525241/
https://www.ncbi.nlm.nih.gov/pubmed/36191892
http://dx.doi.org/10.1016/j.ajogmf.2022.100761
_version_ 1784800665828065280
author Martinez-Baladejo, Maria T.
Graul, Ashley
Gifford, Tyler
McGorry, Dennis
Bell, Joseph
Anastasio, Hannah
Zighelboim, Israel
Tolosa, Jorge E.
author_facet Martinez-Baladejo, Maria T.
Graul, Ashley
Gifford, Tyler
McGorry, Dennis
Bell, Joseph
Anastasio, Hannah
Zighelboim, Israel
Tolosa, Jorge E.
author_sort Martinez-Baladejo, Maria T.
collection PubMed
description
format Online
Article
Text
id pubmed-9525241
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-95252412022-10-03 Pregnancy outcomes after administration of monoclonal antibody therapy for COVID-19 Martinez-Baladejo, Maria T. Graul, Ashley Gifford, Tyler McGorry, Dennis Bell, Joseph Anastasio, Hannah Zighelboim, Israel Tolosa, Jorge E. Am J Obstet Gynecol MFM Research Letter Elsevier Inc. 2023-01 2022-10-01 /pmc/articles/PMC9525241/ /pubmed/36191892 http://dx.doi.org/10.1016/j.ajogmf.2022.100761 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Martinez-Baladejo, Maria T.
Graul, Ashley
Gifford, Tyler
McGorry, Dennis
Bell, Joseph
Anastasio, Hannah
Zighelboim, Israel
Tolosa, Jorge E.
Pregnancy outcomes after administration of monoclonal antibody therapy for COVID-19
title Pregnancy outcomes after administration of monoclonal antibody therapy for COVID-19
title_full Pregnancy outcomes after administration of monoclonal antibody therapy for COVID-19
title_fullStr Pregnancy outcomes after administration of monoclonal antibody therapy for COVID-19
title_full_unstemmed Pregnancy outcomes after administration of monoclonal antibody therapy for COVID-19
title_short Pregnancy outcomes after administration of monoclonal antibody therapy for COVID-19
title_sort pregnancy outcomes after administration of monoclonal antibody therapy for covid-19
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525241/
https://www.ncbi.nlm.nih.gov/pubmed/36191892
http://dx.doi.org/10.1016/j.ajogmf.2022.100761
work_keys_str_mv AT martinezbaladejomariat pregnancyoutcomesafteradministrationofmonoclonalantibodytherapyforcovid19
AT graulashley pregnancyoutcomesafteradministrationofmonoclonalantibodytherapyforcovid19
AT giffordtyler pregnancyoutcomesafteradministrationofmonoclonalantibodytherapyforcovid19
AT mcgorrydennis pregnancyoutcomesafteradministrationofmonoclonalantibodytherapyforcovid19
AT belljoseph pregnancyoutcomesafteradministrationofmonoclonalantibodytherapyforcovid19
AT anastasiohannah pregnancyoutcomesafteradministrationofmonoclonalantibodytherapyforcovid19
AT zighelboimisrael pregnancyoutcomesafteradministrationofmonoclonalantibodytherapyforcovid19
AT tolosajorgee pregnancyoutcomesafteradministrationofmonoclonalantibodytherapyforcovid19